A pioneering human clinical trial examining whether daily 40 Hz multisensory stimulation (combined light and sound) could safely entrain gamma brain rhythms in individuals with mild Alzheimer’s disease and potentially slow functional decline, preserve brain structure, and improve sleep/circadian regulation.

A clinical case study examining whether Vibroacoustic Therapy (VAT) could improve autistic behaviors, social maturity, communication, and emotional regulation in children diagnosed with autism spectrum disorder through structured low-frequency therapeutic intervention.

A 2024 clinical intervention study investigating whether somatosensory music therapy—a vibroacoustic-based therapeutic modality—could significantly reduce depressive symptoms, improve emotional regulation, lower perceived stress, and restore autonomic nervous system balance in adults diagnosed with depressive disorders.

A peer-reviewed clinical study investigating whether vibroacoustic stimulation could enhance physiological recovery, improve parasympathetic nervous system activation, and accelerate post-exercise recovery in competitive athletes following intense physical exertion.

A clinical study investigating whether 40Hz low-frequency sound stimulation (LFSS), a form of Vibroacoustic Therapy, could significantly reduce fibromyalgia symptoms, improve sleep, reduce pain, enhance function, and improve quality of life in women diagnosed with fibromyalgia.

A 3-year longitudinal clinical case study investigating whether 40Hz gamma-frequency Vibroacoustic Therapy (Rhythmic Sensory Stimulation) could help maintain cognition and reduce expected cognitive decline in a woman diagnosed with Alzheimer’s disease.